Table 4.
Multivariate analyses of various clinical parameters in prostate cancer patients
| Parameters | Progression-Free Survival | Cancer-Specific Survival | Overall Survival | |||
|---|---|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Age (years) | 0.975 (0.953–0.997) | 0.028 | – | – | ||
| Gleason Score | < 0.001 | < 0.001 | < 0.001 | |||
| ≤ 7 | 1 | 1 | 1 | |||
| > 7 | 2.392 (1.638–3.495 | 5.073 (2.569–10.020) | 4.003 (2.298–6.974) | |||
| Metastasis | < 0.001 | < 0.001 | < 0.001 | |||
| No | 1 | 1 | 1 | |||
| Yes | 2.930 (2.021–4.247) | 6.091 (3.086–12.024) | 3.245 (1.957–5.378) | |||
| PNI | 0.001 | 0.002 | 0.001 | |||
| < 50.2 | 1 | 1 | 1 | |||
| ≥ 50.2 | 0.521 (0.355–0.765) | 0.421 (0.243–0.728) | 0.429 (0.263–0.698) | |||
Abbreviations: HR Hazard ratio; CI Confidence interval; PSA Prostate-specific antigen; PNI Prognostic nutritional index